Skip to main content

Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variation.

Després PC, Gervais NC, Fogal M, Rogers RKJ, Cuomo CA, Shapiro RS
Genetics. 2025 Oct 8;231(2):iyaf154. doi: 10.1093/genetics/iyaf154. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
234878pRS118CRISPR-Cas9 plasmid for use in Candida albicans. Contains Cas9, NEUT5L integration site, and the sgRNA cloning site (SNR52 promoter)

Antibodies from Article